tlooto

From Risk Categories to Risk-Adapted Care: Comparing the 2025 American Thyroid Association and 2024 Korean Thyroid Association Risk Stratification Systems in Differentiated Thyroid Cancer.

W. Kim, Mijin Kim

2026.6.17Endocrinology and Metabolism

Paper details

Journal
Endocrinology and Metabolism
Published
2026.6.17
Citations
0
References
2
Fields
Medicine

Abstract

In differentiated thyroid cancer (DTC) management, initial risk stratification is a fundamental component that provides the basis for decisions regarding adjuvant therapy and follow-up intensity. The 2025 American Thyroid Association (ATA) and 2024 Korean Thyroid Association (KTA) guidelines employ recurrence risk-based stratification systems at the time of diagnosis. Although the overall framework is comparable, there exists a key structural difference: the ATA guideline adopts a four-tier system (low, low-intermediate, intermediate-high, and high risks) [1], whereas the KTA guideline maintains a three-tier sys-tem (low, intermediate, and high risks) [2,3]. This modification by the ATA may be interpreted as an effort to further refine the heterogeneous intermediate-risk group, which had been associated with a broad range of recurrence risk in previous guidelines [1,4]. These differences should not be interpreted merely as differences in classification structure, because initial risk categories may influence subsequent decisions regarding adjuvant radioactive iodine therapy, thyroid-stimulating hormone suppression, and postoperative surveillance intensity. Because many clinicians may not have the opportunity to compare both guidelines in detail, Table 1 provides a side-by-side summary of the major category-defining differences be-tween the 2024 KTA and 2025 ATA

Citation format

KIM, W.; KIM, Mijin. From risk categories to risk-adapted care: Comparing the 2025 american thyroid association and 2024 korean thyroid association risk stratification systems in differentiated thyroid cancer. Endocrinology and Metabolism, 2026, 41(3): 383–386.